CN102389530A - Traditional Chinese medicine for curing benign prostatic hyperplasia - Google Patents

Traditional Chinese medicine for curing benign prostatic hyperplasia Download PDF

Info

Publication number
CN102389530A
CN102389530A CN2011102585069A CN201110258506A CN102389530A CN 102389530 A CN102389530 A CN 102389530A CN 2011102585069 A CN2011102585069 A CN 2011102585069A CN 201110258506 A CN201110258506 A CN 201110258506A CN 102389530 A CN102389530 A CN 102389530A
Authority
CN
China
Prior art keywords
chinese medicine
parts
prostatic hyperplasia
traditional chinese
fine powder
Prior art date
Application number
CN2011102585069A
Other languages
Chinese (zh)
Inventor
刘新壮
Original Assignee
北京绿源求证科技发展有限责任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京绿源求证科技发展有限责任公司 filed Critical 北京绿源求证科技发展有限责任公司
Priority to CN2011102585069A priority Critical patent/CN102389530A/en
Publication of CN102389530A publication Critical patent/CN102389530A/en

Links

Abstract

A traditional Chinese medicine for curing benign prostatic hyperplasia belongs to the field of traditional Chinese medicines for curing renal and urogenital disorder, and aims at good and fast effect. The traditional Chinese medicine is prepared from dendrobe, angelica sinensis, lucid ganoderma, salvia miltiorrhiza, pseudo-ginseng, fringed pink, jasmine and other raw materials; and the invention has the functions of strengthening the healthy energy, reinforcing the vital energy, tonifying qi, nourishing the blood, promoting the blood circulation, removing the blood stasis, inducing diuresis for removing edema, excreting dampness and treating stranguria, and has the advantages of obvious effect, precise efficacy and faster effect.

Description

A kind of Chinese medicine of treating prostatic hyperplasia
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used to treat male prostatic hyperplasia, the deficiency of two aspects of existence: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect; So that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time; Frequent frequent micturition, urgent micturition, dysurea, unable, the urine retention of urine, urinary incontinence, protracted course of disease; Symptoms such as very misery, and Chang Bingfa urine retention, hematuria, perineal position pain.Patient and family members thereof are very dissatisfied.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating prostatic hyperplasia, and it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, and it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Dendrobii 4---18 parts of 12 parts of Radix Angelicae Sinensis 6---18 portions of Ganodermas 6---
Radix Salviae Miltiorrhizae 6---9 parts of 18 portions of Radix Notoginseng 1---3 portions of Herba Dianthis 3---
Fructus Gardeniae 3---9 parts
The Chinese medicine of this treatment prostatic hyperplasia is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Dendrobii, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Angelicae Sinensis the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, enhancing human body immunity power; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; Be aided with Herba Dendrobii YIN nourishing heat extraction, reinforcing stomach reg fluid; Herba Dianthi, Fructus Gardeniae inducing diuresis for treating stranguria syndrome, Herba Dianthi clearing heat and freeing strangury removing heat from blood, the diuresis of Fructus Gardeniae heat clearing and blood cooling, the two 5 be a usefulness mutually, effect that heat clearing and blood cooling is treating stranguria enhancing is used to treat urinary obstruction, the odynuria effect is distinguished.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, the merit that eliminating dampness by diuresis is treating stranguria, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Dendrobii 400 gram Radix Angelicae Sinensis 600 kairine sesames 600 grams
Radix Salviae Miltiorrhizae 600 gram Radix Notoginseng 100 gram Herba Dianthis 300 grams
Fructus Gardeniae 300 grams
Press predetermined weight, Ganoderma is extracted with decoction and alcohol sedimentation technique; With conventional water extraction process Herba Dendrobii, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted, process extract fine powder 280 grams altogether, Radix Notoginseng is ground into fine powder; Mix with said extracted thing fine powder; Stir, process fine particle, the capsule of packing into No. 0; Process 1266 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight is unit by gram):
Herba Dendrobii 800 gram Radix Angelicae Sinensis 1200 kairine sesames 1200 grams
Radix Salviae Miltiorrhizae 1200 gram Radix Notoginseng 180 gram Herba Dianthis 600 grams
Fructus Gardeniae 600 grams
By above-mentioned same method, process 2466 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
Herba Dendrobii 1200 gram Radix Angelicae Sinensis 1800 kairine sesames 1800 grams
Radix Salviae Miltiorrhizae 1800 gram Radix Notoginseng 260 gram Herba Dianthis 900 grams
Fructus Gardeniae 900 grams
By above-mentioned same method, process 3666 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
8 parts of 8 portions of Ganodermas of 5 parts of Radix Angelicae Sinensis of Herba Dendrobii
4 parts of 1 portion of Herba Dianthis of 8 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
4 parts of Fructus Gardeniaes
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
14 parts of 14 portions of Ganodermas of 10 parts of Radix Angelicae Sinensis of Herba Dendrobii
7 parts of 2 portions of Herba Dianthis of 14 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
7 parts of Fructus Gardeniaes
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 19 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---and frequent micturition, urgent micturition, dysurea, urine are unable, urine retention, urine are hesitated, urine retention; Clinical rectal touch can contact the prostate of increase.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 55 years old-81 years old, 69.3 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine are hesitated, urine retention obviously alleviates; The visible prostate of rectal touch increases (expansion of prostate both sides page or leaf) and alleviates.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent; Urine is hesitated, urine retention alleviates to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.19 philtrums of clinical experiment, produce effects 11 people, effective 6 people, invalid 2 people, total effective rate 89.4%.

Claims (1)

1. Chinese medicine of treating prostatic hyperplasia is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Dendrobii 4---18 parts of 12 parts of Radix Angelicae Sinensis 6---18 portions of Ganodermas 6---
Radix Salviae Miltiorrhizae 6---9 parts of 18 portions of Radix Notoginseng 1---3 portions of Herba Dianthis 3---
Fructus Gardeniae 3---9 parts
The Chinese medicine of this treatment prostatic hyperplasia is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Dendrobii, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Herba Dianthi, Fructus Gardeniae are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
CN2011102585069A 2011-09-03 2011-09-03 Traditional Chinese medicine for curing benign prostatic hyperplasia CN102389530A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011102585069A CN102389530A (en) 2011-09-03 2011-09-03 Traditional Chinese medicine for curing benign prostatic hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011102585069A CN102389530A (en) 2011-09-03 2011-09-03 Traditional Chinese medicine for curing benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
CN102389530A true CN102389530A (en) 2012-03-28

Family

ID=45856995

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011102585069A CN102389530A (en) 2011-09-03 2011-09-03 Traditional Chinese medicine for curing benign prostatic hyperplasia

Country Status (1)

Country Link
CN (1) CN102389530A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631443A (en) * 2012-04-04 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine (TCM) for treating prostatic hyperplasia
CN102670790A (en) * 2012-06-07 2012-09-19 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for curing prostatic hyperplasia
CN109985061A (en) * 2017-12-29 2019-07-09 暨南大学 Application of the dendrobium polysaccharide in preparation prevention and/or treatment prostatic hyperplasia agents
CN109985060A (en) * 2017-12-29 2019-07-09 暨南大学 Dendrobium polysaccharide is in preparation prevention or restores to apply in the drug of Reproductive Damage after chemotherapy
CN109985059A (en) * 2017-12-29 2019-07-09 暨南大学 Dendrobium polysaccharide Reproductive Damage after preparing cancer chemotherapy restores the application in drug

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101972349A (en) * 2010-09-29 2011-02-16 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating benign prostatic hyperplasia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101972349A (en) * 2010-09-29 2011-02-16 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating benign prostatic hyperplasia

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102631443A (en) * 2012-04-04 2012-08-15 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine (TCM) for treating prostatic hyperplasia
CN102670790A (en) * 2012-06-07 2012-09-19 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for curing prostatic hyperplasia
CN109985061A (en) * 2017-12-29 2019-07-09 暨南大学 Application of the dendrobium polysaccharide in preparation prevention and/or treatment prostatic hyperplasia agents
CN109985060A (en) * 2017-12-29 2019-07-09 暨南大学 Dendrobium polysaccharide is in preparation prevention or restores to apply in the drug of Reproductive Damage after chemotherapy
CN109985059A (en) * 2017-12-29 2019-07-09 暨南大学 Dendrobium polysaccharide Reproductive Damage after preparing cancer chemotherapy restores the application in drug

Similar Documents

Publication Publication Date Title
CN102772745B (en) Chinese medicinal preparation for treating cancer and preparation method thereof
CN101934025B (en) Traditional Chinese medicine for clearing away heat and toxic material
CN101843773B (en) Chinese medicament for treating liver cirrhosis
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101766789B (en) Chinese medicine composite for treating appendicitis and preparation method thereof
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN103055130A (en) Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof
CN102697830A (en) Pharmaceutical composition for preventing and treating menstrual disease and preparation method and application of composition
CN102210820A (en) Chinese medicinal composition for treating leukemia
CN101972386A (en) Traditional Chinese medicine for treating diabetic gout
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN101537146B (en) Chinese medicine for treating carcinoma of colon
CN102078527A (en) Traditional Chinese medicine formula for treating urinary calculus
CN102327452A (en) Chinese patent medicament and Chinese decoction for treating initial carbuncle
CN101987138A (en) Chinese medicinal preparation for treating impotence
CN102048899A (en) Traditional Chinese medicine preparation for treating impotence
CN101579508B (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN101530515B (en) Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate
CN102091188A (en) Traditional Chinese medicine for treating diabetic kidney diseases
CN101940674A (en) Chinese medicament for treating diabetic peripheral neuropathy
CN102389473A (en) Traditional Chinese medicine used for treating diabetic constipation
CN101961386A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN102139049A (en) Traditional Chinese medicine for treating diabetic skin pruritus
CN103127351B (en) Traditional Chinese medicine for treating premature menstruation
CN102091225A (en) Traditional Chinese medicine for treating chronic prostatitis

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120328

C02 Deemed withdrawal of patent application after publication (patent law 2001)